Kellner Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Kellner Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,400	Closed	-$1.25M	–	35
2021 Q4	$1.25M	Buy	+13,400	New	+$883K	0.57%	21

Kellner Capital's ARNA Position: Q1 2022 in Review

Kellner Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 13,400 shares — an estimated $1.25M sold.

Kellner Capital first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $1.25M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Kellner Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Kellner Capital sold 13,400 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.25M.
Kellner Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Kellner Capital's Arena Pharmaceuticals Inc position peaked at $1.25M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Kellner Capital's 13F filing for Q1 2022, filed 12 May 2022.